Results 151 to 160 of about 6,338,079 (289)

Selected primer and probe sequences for each multi-parallel assay.

open access: yes, 2016
Selected primer and probe sequences for each multi-parallel assay.
James S. McCarthy (168665)   +6 more
core   +1 more source

Spatial and single‐nuclei transcriptomics reveals idiosyncratic and generic patterns in papillary and anaplastic thyroid cancers

open access: yesMolecular Oncology, EarlyView.
Matched spatial transcriptomics and single‐nuclei RNA‐seq were generated for anaplastic and BRAFV600E papillary thyroid cancers revealing generic and tumor‐specific states occurring in cancer cells and in the tumor microenvironment. In this context, cancer dedifferentiation mirrored organoid maturation through ordered thyroid marker gain/loss ...
Adrien Tourneur   +11 more
wiley   +1 more source

Utility of line probe assay in detecting drug resistance and the associated mutations in patients with extrapulmonary tuberculosis in Addis Ababa, Ethiopia. [PDF]

open access: yesSAGE Open Med, 2022
Diriba G   +16 more
europepmc   +1 more source

Primer and probe sequences for the multiplex genotyping assay.

open access: yes, 2015
Primer and probe sequences for the multiplex genotyping assay.
Tanny J. K. van der Reijden (711604)   +7 more
core   +1 more source

Inhibition of cyclin‐dependent kinases 12/13 using CT7439 as a treatment for colorectal cancer with CDK12 upregulation

open access: yesMolecular Oncology, EarlyView.
The proposed mechanism of action for the CDK12/13 inhibitor and cyclin K degrader, CT7439. CDK12/13 inhibition interrupts transcription elongation, leading to increased DNA damage that results in cell death. This agent is a potentially novel treatment option for patients with colorectal cancer. Created in BioRender. Cyclin‐dependent kinase (CDK) 12 and
Wylie K. Watlington   +10 more
wiley   +1 more source

Early detection of Pre-XDR TB with line probe assay in a high TB burden country. [PDF]

open access: yesAfr Health Sci, 2021
Madukaji L   +11 more
europepmc   +1 more source

Lists of assay ID and probe sequence for RT-PCR.

open access: yes, 2013
Lists of assay ID and probe sequence for RT-PCR.
Yi-Chun Chen (189669)   +4 more
core   +1 more source

In vitro and in silico modelling of ROS1‐positive non‐small cell lung cancer reveals fusion‐dependent tyrosine kinase inhibitor responses

open access: yesMolecular Oncology, EarlyView.
Drug resistance limits treatment success in a subset of lung cancers driven by ROS1 gene alterations. Using patient‐derived cells and computer simulations, we studied three key mutations and how they affect five targeted drugs. The mutations reduced drug effectiveness in different ways by altering protein structure and behavior.
Farhan Ul Haq   +8 more
wiley   +1 more source

Home - About - Disclaimer - Privacy